CV Sciences (CVSI) Assets Average (2011 - 2026)
CV Sciences (CVSI) posted Assets Average of $6.8 million for Q1 2026, down 1.96% sequentially from $7.0 million in Q4 2025, and down 12.77% YoY from $7.8 million in Q1 2025.
CV Sciences (CVSI) Assets Average (2011 - 2026) Analysis & Trends
CV Sciences has reported Assets Average for 16 years, with the latest figure at $6.8 million in Q1 2026.
- Quarterly Assets Average fell 12.77% year-over-year to $6.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.8 million (down 12.77% YoY) and the FY2025 annual result came in at $7.4 million, down 13.07% from the prior year.
- Assets Average retreated to $6.8 million in Q1 2026 per CVSI's latest filing, from $7.0 million in the prior quarter.
- Over five years, Assets Average peaked at $18.2 million in Q1 2022 and troughed at $4.1 million in Q4 2024.
- A 5-year average of $10.0 million and a median of $8.8 million in 2024 frame the typical range for Assets Average.
- The sharpest annual moves came in 2024 and 2025: Assets Average plunged 56.12% in 2024, then surged 68.81% in 2025.
- Over 5 years, Assets Average stood at $14.0 million in 2022, then sank by 32.5% to $9.4 million in 2023, then slumped by 56.12% to $4.1 million in 2024, then soared by 68.81% to $7.0 million in 2025, then retreated by 1.96% to $6.8 million in 2026.
- According to Business Quant data, Assets Average over the past three periods registered $6.8 million, $7.0 million, and $7.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 39.95 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 15.12 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 98.59 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 6.97 Bn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 35.94 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 5.13 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 13.39 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 5.97 Bn |
| 10 | CV Sciences | 4.10 Mn | 3.84 Mn | 1.45 Mn | 6.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.62 Mn |
| Mar 31, 2026 | 6.84 Mn |
| Dec 31, 2025 | 6.98 Mn |
| Sep 30, 2025 | 7.47 Mn |
| Jun 30, 2025 | 7.86 Mn |
| Mar 31, 2025 | 7.84 Mn |
| Dec 31, 2024 | 4.13 Mn |
| Sep 30, 2024 | 4.61 Mn |
| Jun 30, 2024 | 8.68 Mn |
| Mar 31, 2024 | 8.83 Mn |
| Dec 31, 2023 | 9.42 Mn |
| Sep 30, 2023 | 9.76 Mn |
| Jun 30, 2023 | 10.67 Mn |
| Mar 31, 2023 | 12.10 Mn |
| Dec 31, 2022 | 13.96 Mn |
| Sep 30, 2022 | 15.47 Mn |
| Jun 30, 2022 | 17.01 Mn |
| Mar 31, 2022 | 18.17 Mn |
| Dec 31, 2021 | 20.84 Mn |
| Sep 30, 2021 | 25.71 Mn |